Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baojun Wang

Showing results (301-310 of 320) with videos related to

Pageof 32
Sort By:
Developmental Cell|August 7, 2025
The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombiQi Zhang, Yezhen Tan, Qiyang Liang, et al.
Discover Oncology|October 31, 2024
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinomaYongliang Lu, Weihao Chen, Yundong Xuan, et al.
Cancer Letters|May 21, 2021
E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesisDonglai Shen, Yu Gao, Qingbo Huang, et al.
The Journal of Urology|October 4, 2022
Robotic Level IV Inferior Vena Cava Thrombectomy Using an Intrapericardial Control Technique: Is It Safe Without Cardiopulmonary Bypass?Qingbo Huang, Guodong Zhao, Yonghui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 1, 2023
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell CarcinomaLe Li, Xing Zeng, Zheng Chao, et al.
Journal of Endourology|July 28, 2025
Single-Center Experience of Robot-Assisted Nephrectomy and Venous Tumor Thrombectomy: Indications, Surgical Strategies, and Long-Term OutcomesQingbo Huang, Kan Liu, Cheng Peng, et al.
The Journal of Clinical Investigation|February 18, 2025
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signalingWenjie Wei, Hongzhao Li, Shuo Tian, et al.
Signal Transduction and Targeted Therapy|March 14, 2025
Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancerSheng Ma, Zixian Wang, Zezhong Xiong, et al.
Urologic Oncology|March 8, 2021
Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombusHanfeng Wang, Xintao Li, Qingbo Huang, et al.
European Urology|May 20, 2019
Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr OutcomesBaojun Wang, Qingbo Huang, Kan Liu, et al.
Pageof 32

Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
Developmental Cell|August 7, 2025
The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombiQi Zhang, Yezhen Tan, Qiyang Liang, et al.
Discover Oncology|October 31, 2024
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinomaYongliang Lu, Weihao Chen, Yundong Xuan, et al.
Cancer Letters|May 21, 2021
E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesisDonglai Shen, Yu Gao, Qingbo Huang, et al.
The Journal of Urology|October 4, 2022
Robotic Level IV Inferior Vena Cava Thrombectomy Using an Intrapericardial Control Technique: Is It Safe Without Cardiopulmonary Bypass?Qingbo Huang, Guodong Zhao, Yonghui Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 1, 2023
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell CarcinomaLe Li, Xing Zeng, Zheng Chao, et al.
Journal of Endourology|July 28, 2025
Single-Center Experience of Robot-Assisted Nephrectomy and Venous Tumor Thrombectomy: Indications, Surgical Strategies, and Long-Term OutcomesQingbo Huang, Kan Liu, Cheng Peng, et al.
The Journal of Clinical Investigation|February 18, 2025
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signalingWenjie Wei, Hongzhao Li, Shuo Tian, et al.
Signal Transduction and Targeted Therapy|March 14, 2025
Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancerSheng Ma, Zixian Wang, Zezhong Xiong, et al.
Urologic Oncology|March 8, 2021
Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombusHanfeng Wang, Xintao Li, Qingbo Huang, et al.
European Urology|May 20, 2019
Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr OutcomesBaojun Wang, Qingbo Huang, Kan Liu, et al.
Pageof 32